Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  BB Biotech AG    BION   CH0038389992

BB BIOTECH AG

(BION)
  Report  
Delayed Quote. Delayed Swiss Exchange - 12/11 07:23:23 am
67.25 CHF   +0.30%
11/20BB BIOTECH AG : Nomination
CO
10/18BB BIOTECH : publishes its interim report
EQ
10/18BB BIOTECH AG : Political factors weigh on biotech equity markets
EQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

BB BIOTECH AG : Notification and public disclosure of transactions by persons

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/27/2019 | 11:50am EST


Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

27.05.2019 / 17:40
The issuer is solely responsible for the content of this announcement.


1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Title: Dr.
First name: Thomas
Last name(s): von Planta

2. Reason for the notification

a) Position / status
Position: Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
BB BIOTECH AG

b) LEI
391200MBZQNPFHIVKO34 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Share
ISIN: CH0038389992

b) Nature of the transaction
Acquisition

c) Price(s) and volume(s)
Price(s) Volume(s)
69.03 CHF 61366.16 CHF

d) Aggregated information
Price Aggregated volume
69.03 CHF 61366.16 CHF

e) Date of the transaction
2019-05-24; UTC+2

f) Place of the transaction
Name: SIX Swiss Exchange
MIC: XSWX



27.05.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: BB BIOTECH AG
Schwertstrasse 6
8200 Schaffhausen
Switzerland
Internet: www.bbbiotech.ch

 
End of News DGAP News Service

51397  27.05.2019 


© EQS 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BB BIOTECH AG
11/20BB BIOTECH AG : Nomination
CO
10/18BB BIOTECH : publishes its interim report
EQ
10/18BB BIOTECH AG : Political factors weigh on biotech equity markets
EQ
10/18BB BIOTECH AG : 3rd quarter results
CO
09/30BB BIOTECH AG : 3rd quarter report
CO
07/19BB BIOTECH : publishes its interim report
EQ
07/19BB BIOTECH AG : Consolidation leaves a mark on results in the second quarter
EQ
06/30BB BIOTECH AG : Half-year report
CO
05/27BB BIOTECH AG : Notification and public disclosure of transactions by persons
EQ
05/14ASHTEAD : What's at stake for Europe Inc in a trade spat with Washington
RE
More news
Financials (CHF)
Sales 2019 209 M
EBIT 2019 297 M
Net income 2019 321 M
Debt 2019 85,0 M
Yield 2019 4,01%
P/E ratio 2019 14,5x
P/E ratio 2020 22,8x
EV / Sales2019 18,2x
EV / Sales2020 1 900x
Capitalization 3 715 M
Chart BB BIOTECH AG
Duration : Period :
BB Biotech AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BB BIOTECH AG
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Average target price 74,50  CHF
Last Close Price 67,05  CHF
Spread / Highest target 23,8%
Spread / Average Target 11,1%
Spread / Lowest Target -1,57%
EPS Revisions
Managers
NameTitle
Erich Hunziker Chairman
Michael Hutter Head-Finance & Compliance
Clive A. Meanwell Vice Chairman
Klaus Strein Director
Thomas von Planta Director
Sector and Competitors
1st jan.Capitalization (M$)
BB BIOTECH AG14.81%3 771
IQVIA HOLDINGS INC.25.78%28 353
LONZA GROUP31.49%25 241
INCYTE CORPORATION50.53%20 618
SEATTLE GENETICS, INC.101.16%19 535
CELLTRION, INC.--.--%17 845